Red x ahead

Today we want to introduce you to data AG – an operative holding company engaged in the global penetration of highly scalable innovative technologies, utilizing & commercializing scientific IP and software.

One of their portfolio companies is the biotech a:head, that just recently closed a 7-digit EUR equity round with a consortium of investors including data AG, their seed investor.

a:head bio AG, is an Austrian biotech company focusing on the development of next generation therapeutics for the treatment of brain disorders based on human cerebral organoids. The company follows a standard biotech business model turning private and public funding into a valuable portfolio of therapeutic assets with the main objective to improve quality of life for patients suffering from diseases of the central nervous system.

More about a:head